Samples of human endometrial carcinomas and cervical adenocarcinomas were screened for the presence of single site DNA mutations at codon 12 of the K-ras gene using dot blot hybridization of DNA amplified by the polymerise chain reaction (POR). Of 21 cases of endometrial carcinoma, point mutations were observed in three cases (14.3%). Mutation from GOT to GTT was seen in one case, and mutation to GAT was observed in two cases. Of seven cases of cervical adenocarcinoma, point mutations were noted in two cases (28.6%). Mutation from GOT to GTT and double mutation to OAT and GOT were in one case each. However, no correlation was found between the presence of point mutation and age, clinical stage, or depth of muscular invasion. With respect to prognosis, of five patients with point mutation, one with cervical carcinoma died, and of 23 patients without mutation, one with endometrial carcinoma died.
The human ras gene family is one of the potential targets for mutational changes that play a role in human tumorigenesis. In more than 20% of certain type of tumors specifc point mutations in K-ras, H-ras and N-ras at codons 12,13 and 61 are known to cause activation of these protooncogenes (Bos 1989 ). Precise data on the incidence of these mutations in tumors, on their tumor or tissue specificity and their clinical relevance are limited so far.
In this study, we have examined the incidence of K-ras mutations in cases of endometrial carcinoma and cervical adenocarcinoma at the most commonly re-placed site, codon 12.
MATERIALS AND METHODS

Materials
Analyzed were 23 patients with endometrial carcinoma and 7 with cervical adenocarcinoma who underwent surgery at the Department of Obstetrics and Gynecology of Tohoku University between 1986 and 1990. All samples were fixed with formalin and embedded in paraffin.
Methods
A portion of cancer tissue was identified in the paraffin-embedded samples by hematoxylen and eosin staining, and two 10-p m thick sections were cut. DNA was extracted by the phenol chloroform methods, and lpg was used for polymerase chain reaction (PCR). A Gene Amp DNA amplification reagent kit (Perkin-Elmer-Cetus Corp., CT, USA) and ras oncogene primer (Takara, Tokyo) were used for PCR. The extracted DNA was quantified, and subjected to PCR using lag of uniform template DNA. When sections were used directly, the entire 30 p1 was used. Denaturation for one min at 94°C ; annealing for two min at 60°C, and extension for three min at 72°C constituted one cycle of PCR, and 80 cycles in total were conducted.
After the first 40 cycles, 2.5 units of Tag polymerase were added, and another 40 cycles were carried out. A part of PCR products was subjected to 3% agarose gel electorophoresis, to confirm DNA amplification. Dot blot hybridization was conducted according to the method of Verlaan-de Vries et al., (1986) . Three microliters each of PCR reactant liquid was spotted on a nylon filter to fix DNA, then left in pre-hybridizing solution at 56°C overnight. Subsequently, the material was subjected to hybridization for 3 hr at 56°C in pre-hybridizing solution and 32P-labeled oligomer DNA probe. Finally, autoradiography was conducted once at -70°C. SW 480, which is a colorectal adenocarcinoma cell line (Capon et al. 1983) , and human placenta were used as positive and negative controls, respectively.
PCR primers and DNA probe
In the PCR analysis of the ras gene, two sets of 20-base oligonucleotide primers are used, which hybridize to opposite strands of the genomic DNA flanking the target sequence around codon 12. After repeated cycles of denaturation, annealing, and chain elongation, DNA target sequences are generated (Fig. 1) . g primers and pro be in relation to the ras gene (bp, mutations were observed in three (Table 1) . Mutation from wild type GOT (Gly) to GTT (Val) was observed in one case, while mutation to OAT (Asp) was seen in two cases( Fig. 2 ; case No. 6). The detection rate was 14.3% (3 of 21 cases). Amplification of PCR products was observed in all seven cases of cervical adenocarcinoma, while point mutations were noted in two cases (Table 2) . Mutation from wild type GOT (Gly) to GTT (Val) ( Fig. 2 ; case No. 15) and double mutation to OAT (Asp) and GCT (Ala) were seen in one case ( Fig. 2 ; case No. 16) each. The detection rate was 28.6% (2 of 7 cases).
RESULTS
No correlation was seen between the appearance of point mutation and age, stage, grade of histological differentiation, or depth of muscular invasion in cases of endometrial carcinoma and cervical adenocarcinoma. With respect to prognosis, of five patients with point mutation, one died ( cervical adenocarcinoma, Ib stage), whereas of 23 patients without mutation, one died (endometrial carcinoma, III stage).
Major oncogenes in Lion, has been detected which are the DISCUSSION point mutation, possibily contributing to activaras oncogenes and the neu (c-erbB-2) oncogenes. Among cases of ras mutation, K-ras mutation is frequently observed in cases of adenocarcinoma, including pancreas carcinoma, lung carcinoma, and colon carcinoma, and its participation in canceration is strongly suspected (Bos et al. 1987 ; Almoguera et al. 1988 ). However, there have been very few reports on adenocarcinoma in the field of gynecology, and the actual status of the K-ras oncogene in this area has not been clarified (Van't Veer et al. 1988; Lester and Cauchi 1990). Accordingly, in the current study, we studied K-ras mutations in cases of endometrial carcinoma and cervical adenocarcinoma. Point mutations were obser- 
